New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 6, 2013
07:33 EDTINFIInfinity Pharmaceuticals price target raised to $55 from $38 at RBC Capital
RBC Capital expects Infiinity's stock to be pushed higher by favorable data at ASCO/ASH. The firm thinks the stock's valuation is attractive, and it maintains an Outperform rating on the shares.
News For INFI From The Last 14 Days
Check below for free stories on INFI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for INFI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use